Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 233 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		"Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Active				18 and over				Other				2005-060-version1a NCT00338481


2.		Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Active				18 to 75				Other				UMCN-AKF 07.02 EudraCTnr 2007-003347-73, NCT00588835


3.		Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Diagnostic				Approved-not yet active				60 to 80				Other				PROLOG NCT00675168


4.		Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Approved-not yet active				18 and over				Other				2612-3681 NCT00724581


5.		Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Diagnostic				Active				15 and over				Other				SP-11-0035 NCT00123760


6.		Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care, Treatment				Active				18 and over				Other				001-0015-211 NCT00127387


7.		A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 to 75				Other				Haema CBF SCLC UK/AS 01 NCT00168896


8.		An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Tissue collection/Repository				Active				19 and over				NCI, Other				04-109 NCT00132704


9.		18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic				Active				19 to 90				Other				R05-0076 NCT00207298

Last Modified: 5/22/2008 First Published: 8/24/2006


10.		Phase III Randomized Study of Printed Psychoeducational Interventions in Patients Completing Active Treatment For Stage I-IIIA Breast, Colorectal, Prostate, or Thoracic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Educational/Counseling/Training, Supportive care				Active				18 and over				NCI				FCCC-FCRB-04-002-P NCT00372840

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute